Canada dry powdered inhaler market is anticipated to grow at a significant CAGR of around 6.8% during the forecast period. The major factors that are contributing significantly to the market growth include growing geriatric population susceptible to respiratory diseases such as asthma and COPD, and high healthcare expenditure. Asthma causes around 350 mortalities every year in the country and it is estimated that over 2 million people live in Canada with Asthma every year. Asthma rates have been increased in Canada over the last 20 years. Although, the fatality rate due to asthma has decreased slightly due to the availability of effective medications. COPD is another respiratory disorder that is the fourth most common cause of mortality in the country and particularly affects women.
To Request a Sample of our Report on Canada Dry Powdered Inhaler Market: https://www.omrglobal.com/request-sample/canada-dry-powdered-inhaler-market
Canada dry powdered inhaler market is segmented based on type, application, and end-user. Based on the type, preventive, reliever, and long-acting bronchodilators inhaler are analyzed. The preventive dry powdered inhaler segment led the global dry powdered inhaler market in 2018. Preventive inhalers are most widely used in the treatment of asthma in children and adults. These inhalers do not entail side effects for long-term use, and exceptionally decreases the possibility of an asthma exacerbation. The preventive inhalers further reduce the airways swelling and hence, are recommended for regular use by the physician. Some of the preventive inhalers available in the market include Budesonide and Fluticasone. Moreover, based on the application, the market has been classified into asthma and COPD diseases. In addition, based on the end-user, homecare and hospitals and clinics have been analyzed.
(Get 15% Discount on Buying this Report)
A full Report of Canada Dry Powdered Inhaler Market is Available at: https://www.omrglobal.com/industry-reports/canada-dry-powdered-inhaler-market
Canada Dry Powdered Inhaler Market Segmentation
By Type
· Preventive Inhaler
· Reliever Inhaler
· Long Acting Bronchodilators Inhaler
By Application
· Asthma
· Chronic Obstructive Pulmonary Disease (COPD)
By End-User
· Homecare
· Hospitals and Clinics
(This release has been published on OMR Industry Journal. OMR Industry Journal is not responsible for any content included in this release.)
